BRIEF RESEARCH REPORT
Accepted on 07 Jul 2025
TP53 and KRAS co-mutations are associated with worse outcomes in mucinous ovarian carcinomas
doi 10.3389/fonc.2025.1573801
- Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
- Research Topics
- Exploring Molecular Mechanisms in Cancer through Tumor Molecular Pathology
Exploring Molecular Mechanisms in Cancer through Tumor Molecular Pathology
426
Total downloads
4,083
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
CASE REPORT
Accepted on 07 Jul 2025
Case report: Two cases of bronchiolar adenoma/ciliated muconodular papillary tumor characterized by significant basal cell hyperplasia and squamous metaplasia
doi 10.3389/fonc.2025.1617720
ORIGINAL RESEARCH
Accepted on 30 Jun 2025
Genomic instability and CCNE1 amplification as emerging biomarkers for stratifying High-Grade Serous Ovarian Cancer
doi 10.3389/fonc.2025.1633410
TECHNOLOGY AND CODE
Accepted on 26 Jun 2025
A structure-based tool to interpret the significance of kinase mutations in clinical next generation sequencing in cancer
doi 10.3389/fonc.2025.1599389
ORIGINAL RESEARCH
Published on 19 May 2025
Preclinical NCI-MPACT: prospective modeling of the mutation-based NCI-MPACT clinical trial therapeutic strategy in patient-derived xenograft models
doi 10.3389/fonc.2025.1571635
- 991 views
CASE REPORT
Published on 11 Apr 2025
Metastatic INI-1−deficient undifferentiated lung cancer with EGFR 19del mutation identified in pleural effusion: a case report and review of the literature
doi 10.3389/fonc.2025.1539309
- 711 views
Published in
Frontiers in Oncology
Cancer Molecular Targets and Therapeutics
Participating Journals
Frontiers in Genetics
- 2.8 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: